← Eichor
Study identifier: NCT06057129 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Unsupervised Therapy After Stroke in the Home Setting with a Hand Rehabilitation Device (ReHandyBot)

Condition: Stroke  ·  Sponsor: Swiss Federal Institute of Technology

PhaseNA
Planned participants15
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

The ReHandyBot is a robot for hand rehabilitation after stroke. The aims of this study are (1) to investigate the feasibility of unsupervised therapy with the ReHandyBot with stroke inpatients, first in a rehabilitation clinic and then at participants' home, (2) to evaluate the usability of the ReHandyBot (user interface, implemented exercises, and gaming environment, which were adapted for independent usage), and (3) to quantify the dose of additional robotic therapy that patients perform without supervision. The study consists of two primary phases. The first is a familiarization phase performed at the clinic, where therapists teach to the participants how to perform the exercises with the robot. Then, if capable of training with the robot safely, after discharge from the clinic participants can bring the robot home and autonomously train with it. The hypothesis is that unsupervised therapy might be a possible way to increase therapy dose for stroke patients, with the potential to further improve recovery of hand function, with minimal additional burden for therapists and for the healthcare system.

This description comes directly from the study's public registry record.

Talk to the study team

Giada Devittori, M. Sc.  ·  +41 44 510 72 31  ·  giada.devittori@hest.ethz.ch

Always discuss trial participation with your own doctor first.

Locations (1)

Clinica Hildebrand Centro di riabiliazione BrissagoBrissago, Canton Ticino, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06057129